GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Revenue, FY2025
- £32.7B
- YoY, FY2025
- +4.1%
- 5-year CAGR
- +6.0%
- 10-year CAGR
- +3.2%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| FY2025 | £32.7B | +4.1% |
| FY2024 | £31.4B | +3.5% |
| FY2023 | £30.3B | +3.4% |
| FY2022 | £29.3B | +18.7% |
| FY2021 | £24.7B | +1.4% |
| FY2020 | £24.4B | −27.8% |
| FY2019 | £33.8B | +9.5% |
| FY2018 | £30.8B | +2.1% |
| FY2017 | £30.2B | +8.2% |
| FY2016 | £27.9B | +16.6% |
| FY2015 | £23.9B | — |